Cited 0 time in
PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND TOLERABILITY OF J2H-1702, A NOVEL 11Β-HSD1 INHIBITOR, AFTER MULTIPLE ORAL ADMINISTRATION
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 이상원 | - |
| dc.date.accessioned | 2025-01-09T23:30:34Z | - |
| dc.date.available | 2025-01-09T23:30:34Z | - |
| dc.date.issued | 2024-11-14 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205796 | - |
| dc.title | PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND TOLERABILITY OF J2H-1702, A NOVEL 11Β-HSD1 INHIBITOR, AFTER MULTIPLE ORAL ADMINISTRATION | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 2024 대한임상약리학회 추계학술대회 | - |
| dc.citation.conferencePlace | 광주 김대중 컨벤션 센터 4층 컨벤션홀 로비 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
